eHealthMe - FDA and Social Media, Personalized eHealthMe - FDA and Social Media, Personalized

FDA and Social Media, Personalized

Tools
Drugs A-Z       Conditions A-Z       Feature support groups

Review: Pau d'arco side effects

In this review, we analyze Pau d'arco side effects by the time on the drug, gender and age (0-60+) of the people who have side effects while taking Pau d'arco. The review is based on 2 people who have side effects while taking Pau d'arco from FDA and social media, and is updated regularly.

Get connected: join a mobile support group for people who have Pau d'arco side effects >>>

What is Pau d'arco

Pau d'arco (latest outcomes) has active ingredients of pau d'arco.

It can also be called: Taheebo Tea, Tecoma ipe, Trumpet Bush, Bignonia heptaphylla, Ipe, Ipe Roxo, Ipes, Lapacho, Lapacho Colorado, Lapacho Morado, Purple Lapacho, Red Lapacho, Tabebuia avellanedae, Tabebuia heptaphylla, Tabebuia ipe, Tabebuia palmeri, Tabebuia impetiginosa, Taheebo.

On Oct, 31, 2014: 2 people who reported to have side effects when taking Pau d'arco are studied

 outcomes

Most common side effects over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Flun/an/an/an/an/an/an/a
Digoxin Toxicity

Most common side effects by gender * :

FemaleMale
FluDigoxin Toxicity

Most common side effects by age * :

0-12-910-1920-2930-3940-4950-5960+
n/an/an/an/an/an/aFluDigoxin Toxicity

* Some reports may have incomplete information.

Browse Pau d'arco side effects from A to Z:

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Are you taking Pau d'arco?

More questions for: Pau d'arco

More reviews for: Pau d'arco

Studies of common Pau d'arco drug interactions:

Browse Pau d'arco drug interactions with drugs from A to Z:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

44 million health professionals and patients have studied on eHealthMe. Recent studies:

- Amoxicillin for a 37-year old woman who has Ear Infection (11 minutes ago)

- Citalopram Hydrobromide for a 46-year old man who has Depression (22 minutes ago)

- Gonal-f for a 33-year old woman who has Infertility (1 hour ago)

 

Recent mobile support groups

- Insomnia

- Osteoporosis

- Prolia

- Back Injury

- Vicodin

 

Recent user comments

- "I have been experiencing some chest discomfort on and ... " (14 minutes ago)

- "Anxiety-driven retching when forcd to perform/present ... " (25 minutes ago)

- "Horrible pain all over can't sleep due to sore throat ... " (4 hours ago)

 

Recent searches

- Eye Twitch
- Ephedra Equisetina
- Pms
- Pentazocine And Naloxone Hydrochlorides
- Clindamycin Hydrochloride (lannett) Eq 300mg Base

   

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.